ID   N14A
AC   CVCL_4V86
DR   ECACC; 16110902
DR   Wikidata; Q54907316
RX   PubMed=25929336;
CC   Doubling time: ~48 hours (PubMed=25929336).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Appendix; UBERON=UBERON_0001154.
ST   Source(s): ECACC=16110902
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 8,13
ST   D18S51: 16,18
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 5,7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3345; Pseudomyxoma peritonei
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
RX   PubMed=25929336; DOI=10.18632/oncotarget.3198; PMCID=PMC4484419;
RA   Roberts D.L., O'Dwyer S.T., Stern P.L., Renehan A.G.;
RT   "Global gene expression in pseudomyxoma peritonei, with parallel
RT   development of two immortalized cell lines.";
RL   Oncotarget 6:10786-10800(2015).
//